Myriad Pharmaceuticals, Inc.
Records under this name other than patents Myriad Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Myriad Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,595,401 | Therapeutic Compounds and Their Use in Cancer Formerly held In force · High confidence | In force | High confidence | |
| US 8,476,285 | Purine-Core Inhibitors of HSP90 and Their Use in Treating Cancer Formerly held In force · High confidence | In force | High confidence | |
| US 9,505,800 | Extended triterpene derivatives Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,653,139 | Drug substance preparations, pharmaceutical compositions and dosage forms Formerly held Lapsed on the fee record Ended Feb 18, 2026 · USPTO record | Lapsed on the fee record | Ended Feb 18, 2026 | USPTO record |
| US 8,318,425 | Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein Formerly held Term ended Term ended Sep 11, 2024 · USPTO record | Term ended | Term ended Sep 11, 2024 | USPTO record |
| US 7,273,889 | Nmda Receptor Antagonist Formulation with Reduced Neurotoxicity Formerly held Term ended Term ended Jul 10, 2023 · High confidence | Term ended | Term ended Jul 10, 2023 | High confidence |
| US 7,008,941 | Reverse-Turn Mimetics and Methods Relating Thereto Formerly held Term ended Term ended May 26, 2023 · High confidence | Term ended | Term ended May 26, 2023 | High confidence |
| US 6,943,157 | Reverse-Turn Mimetics and Composition and Methods Relating Thereto Formerly held Term ended Term ended Feb 27, 2023 · High confidence | Term ended | Term ended Feb 27, 2023 | High confidence |
| US 6,943,167 | Helix Mimetics and Composition and Methods Related Thereto Formerly held Term ended Term ended Aug 29, 2022 · High confidence | Term ended | Term ended Aug 29, 2022 | High confidence |
| US 7,714,022 | Pyrrole Derivatives as Therapeutic Compounds Formerly held Lapsed on the fee record Ended May 11, 2022 · High confidence | Lapsed on the fee record | Ended May 11, 2022 | High confidence |